Logo image of NXE

NEXGEN ENERGY LTD (NXE) Stock Fundamental Analysis

USA - NYSE:NXE - CA65340P1062 - Common Stock

8.72 USD
-0.1 (-1.13%)
Last: 10/3/2025, 8:04:00 PM
8.7 USD
-0.02 (-0.23%)
After Hours: 10/3/2025, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NXE. NXE was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. NXE may be in some trouble as it scores bad on both profitability and health. NXE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NXE had negative earnings in the past year.
In the past year NXE has reported a negative cash flow from operations.
NXE had negative earnings in 4 of the past 5 years.
In the past 5 years NXE always reported negative operating cash flow.
NXE Yearly Net Income VS EBIT VS OCF VS FCFNXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

NXE has a Return On Assets of -12.53%. This is amonst the worse of the industry: NXE underperforms 86.26% of its industry peers.
NXE has a worse Return On Equity (-18.89%) than 78.20% of its industry peers.
Industry RankSector Rank
ROA -12.53%
ROE -18.89%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
NXE Yearly ROA, ROE, ROICNXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

NXE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NXE Yearly Profit, Operating, Gross MarginsNXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, NXE has more shares outstanding
NXE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NXE has a worse debt to assets ratio.
NXE Yearly Shares OutstandingNXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NXE Yearly Total Debt VS Total AssetsNXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

NXE has an Altman-Z score of 7.41. This indicates that NXE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NXE (7.41) is better than 91.94% of its industry peers.
NXE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NXE (0.01) is better than 82.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 7.41
ROIC/WACCN/A
WACCN/A
NXE Yearly LT Debt VS Equity VS FCFNXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.75 indicates that NXE may have some problems paying its short term obligations.
NXE has a Current ratio of 0.75. This is in the lower half of the industry: NXE underperforms 73.93% of its industry peers.
NXE has a Quick Ratio of 0.75. This is a bad value and indicates that NXE is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.75, NXE is not doing good in the industry: 63.98% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
NXE Yearly Current Assets VS Current LiabilitesNXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

3

3. Growth

3.1 Past

NXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.52%, which is quite good.
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -8.36% on average over the next years.
Based on estimates for the next years, NXE will show a very strong growth in Revenue. The Revenue will grow by 59.79% on average per year.
EPS Next Y-29.86%
EPS Next 2Y3.93%
EPS Next 3Y-8.65%
EPS Next 5Y-8.36%
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y59.79%

3.3 Evolution

NXE Yearly Revenue VS EstimatesNXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2024 2029 2030 2031 2032 1B 2B 3B
NXE Yearly EPS VS EstimatesNXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.1 -0.2 -0.3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NXE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NXE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NXE Price Earnings VS Forward Price EarningsNXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NXE Per share dataNXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

NXE's earnings are expected to decrease with -8.65% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.93%
EPS Next 3Y-8.65%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NXE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEXGEN ENERGY LTD

NYSE:NXE (10/3/2025, 8:04:00 PM)

After market: 8.7 -0.02 (-0.23%)

8.72

-0.1 (-1.13%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners58.72%
Inst Owner Change0%
Ins Owners4.68%
Ins Owner ChangeN/A
Market Cap4.97B
Analysts81.18
Price Target10 (14.68%)
Short Float %18.86%
Short Ratio12.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.3%
Min EPS beat(2)-296.04%
Max EPS beat(2)241.44%
EPS beat(4)2
Avg EPS beat(4)-39.73%
Min EPS beat(4)-296.04%
Max EPS beat(4)241.44%
EPS beat(8)3
Avg EPS beat(8)-68.3%
EPS beat(12)4
Avg EPS beat(12)-151.78%
EPS beat(16)4
Avg EPS beat(16)-158.46%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.64%
PT rev (3m)0.73%
EPS NQ rev (1m)16.67%
EPS NQ rev (3m)9.99%
EPS NY rev (1m)-29.95%
EPS NY rev (3m)-95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.76
P/tB 6.76
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS1.29
TBVpS1.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.53%
ROE -18.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-2.29%
ROA(5y)-11.88%
ROE(3y)-3.42%
ROE(5y)-30.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5507.06%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 7.41
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5324.66%
Cap/Depr(5y)3796.13%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-600%
EPS Next Y-29.86%
EPS Next 2Y3.93%
EPS Next 3Y-8.65%
EPS Next 5Y-8.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y59.79%
EBIT growth 1Y47.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-4.28%
EBIT Next 3Y2.63%
EBIT Next 5Y4.7%
FCF growth 1Y-28.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.24%
OCF growth 3YN/A
OCF growth 5YN/A